Pubblicazioni

Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience

2024 - NEUROTHERAPEUTICS
Ruggieri, Serena; Ianniello, Antonio; Copetti, Massimiliano; Altieri, Marta; Centonze, Diego; Cortese, Antonio; De Giglio, Laura; Fantozzi, Roberta; Tortorella, Carla; Gasperini, Claudio; Grimaldi, Luigi Me; Landi, Doriana; Marfia, Girolama A; Mirabella, Massimiliano; Nistri, Riccardo; Nociti, Viviana; Oddo, Oscar; Romano, Silvia; Salemi, Giuseppe; Salvetti, Marco; Pozzilli, Carlo; Petracca, Maria

Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules

2024 - MULTIPLE SCLEROSIS AND RELATED DISORDERS
Leodori, Giorgio; Mancuso, Marco; Maccarrone, Davide; Tartaglia, Matteo; Ianniello, Antonio; Baione, Viola; Ferrazzano, Gina; Malimpensa, Leonardo; Belvisi, Daniele; Berardelli, Alfredo; Pozzilli, Carlo; Conte, Antonella

COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach

2020 - MULTIPLE SCLEROSIS AND RELATED DISORDERS
Borriello, Giovanna; Ianniello, Antonio

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma